Response Signatures of Alcohol-Related Birth Defects
酒精相关出生缺陷的反应特征
基本信息
- 批准号:6649349
- 负责人:
- 金额:$ 5.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-29 至 2004-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Fetal alcohol syndrome (FAS) refers to a recognized pattern of birth defects that occurs in a subset of children born to women who consume alcohol during pregnancy. Typical alcohol- related birth defects include microencephaly, microphthalmia, deficiencies of the facial prominences and visceral arches, as well as effects on the heart, great vessels, and thymus. Understanding disease mechanisms in prenatal alcohol exposure depends upon learning what metabolic and regulatory pathways mediate critical steps leading to dysmorphogenesis. The research proposed here uses gene expression arrays and bioinformatics to probe the origins of alcohol-related birth defects in an acute animal model. Many disease endpoints in human alcohol-related birth defects can be induced acutely in C57BL/6J mice during gastrulation-neurulation phases of development. Specific Aim 1 will survey the normal (developmental) gene expression for structures commonly malformed in alcohol-related birth defects. Parameterization will landmark key stages of ocular and hindbrain development across the window of vulnerability to ethanol-induced teratogenesis (days 8-10 of gestation) using C7BL/6J and CD-1 strains of mice that are differentially responsive to acute gestational exposure of ethanol. Conventional microdissection and laser capure microdissection will isolate specific precursor target cell populations from the test and reference samples. Specific Aim 2 will enumerate alcohol-related changes of gene expression within the exposure-disease continuum. Parameterization will entail dose-response, time after exposure, and strains differing in sensitivity. Emphasis will be the developing eye and hindbrain for exposure on day 9 of gestation. Specific Aim 3 is to initiate a functional genomics/computational biology pipeline for comprehensive pattern recognition, exploration, and validation of alcohol-related changes in developing target organs. Microarray data will be amalgamated into the first gene expression reference database for detecting alcohol-related effects on the developing embryo. This effort will enable computation of critical response signatures that represent core phenomena in disease mechanisms. By studying multigenic response signatures we hope to define the various metabolic and regulatory pathways set into disarray during critical periods of prenatal ethanol exposure. At ends, we expect this knowledge will enable researchers to identify mechanisms of alcohol-related birth defects and noninvasive strategies toward intervention. Project-generated resources will include the design and construction of specialized arrays focused on the genes emerging as responsive to ethanol intoxication, as well as a relational database made accessible to the scientific community through the world-wide web.
胎儿酒精综合症(FAS)是指一种公认的出生缺陷模式,发生在怀孕期间饮酒的女性所生的孩子中。 典型的与酒精相关的出生缺陷包括小脑畸形、小眼畸形、面部突出和内脏弓缺陷,以及对心脏、大血管和胸腺的影响。了解产前酒精暴露的疾病机制取决于了解哪些代谢和调节途径介导导致畸形发生的关键步骤。 这里提出的研究利用基因表达阵列和生物信息学来探讨急性动物模型中与酒精相关的出生缺陷的起源。 C57BL/6J 小鼠在发育的原肠胚形成-神经形成阶段可急性诱导人类酒精相关出生缺陷的许多疾病终点。 具体目标 1 将调查酒精相关出生缺陷中常见畸形结构的正常(发育)基因表达。参数化将通过使用对妊娠期急性乙醇暴露有不同反应的 C7BL/6J 和 CD-1 小鼠品系,在乙醇诱导的致畸脆弱性窗口(妊娠第 8-10 天)中确定眼部和后脑发育的关键阶段。 传统显微切割和激光捕获显微切割将从测试和参考样品中分离出特定的前体靶细胞群。具体目标 2 将列举暴露-疾病连续体中与酒精相关的基因表达变化。参数化将涉及剂量反应、暴露后时间以及敏感性不同的菌株。 重点是妊娠第 9 天暴露的正在发育的眼睛和后脑。具体目标 3 是启动功能基因组学/计算生物学流程,以对发育中的目标器官中与酒精相关的变化进行全面的模式识别、探索和验证。 微阵列数据将被合并到第一个基因表达参考数据库中,用于检测酒精对发育中胚胎的相关影响。 这项工作将能够计算代表疾病机制中核心现象的关键反应特征。 通过研究多基因反应特征,我们希望确定在产前乙醇暴露的关键时期陷入混乱的各种代谢和调节途径。 最后,我们希望这些知识将使研究人员能够确定与酒精相关的出生缺陷的机制和非侵入性干预策略。 项目生成的资源将包括设计和构建专门的阵列,重点关注对乙醇中毒有反应的基因,以及科学界通过万维网访问的关系数据库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas B Knudsen其他文献
Evaluation of biologically based dose-response modeling for developmental toxicity: a workshop report.
基于生物学的发育毒性剂量反应模型的评估:研讨会报告。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:0
- 作者:
Christopher Lau;Melvin E. Andersen;D. Crawford‐Brown;R. Kavlock;Carole A. Kimmel;Thomas B Knudsen;Ken Muneoka;John M. Rogers;R. Setzer;Gary Smith;Rochelle W. Tyl - 通讯作者:
Rochelle W. Tyl
Thomas B Knudsen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas B Knudsen', 18)}}的其他基金
Speaker Travel & Session Cost for / Teratology Social Annual Meeting - 300.1
扬声器旅行
- 批准号:
7334533 - 财政年份:2007
- 资助金额:
$ 5.15万 - 项目类别:
Perinatal Breast Cancer Programming: fat and estrogens
围产期乳腺癌规划:脂肪和雌激素
- 批准号:
7082042 - 财政年份:2005
- 资助金额:
$ 5.15万 - 项目类别:
Perinatal Breast Cancer Programming--Fat and estrogens
围产期乳腺癌规划——脂肪和雌激素
- 批准号:
6938771 - 财政年份:2005
- 资助金额:
$ 5.15万 - 项目类别:
2004 TERATOLOGY SOCIETY MEETINGS: TRAVEL FOR STUDENTS
2004 年畸形学学会会议:学生旅行
- 批准号:
6805341 - 财政年份:2004
- 资助金额:
$ 5.15万 - 项目类别:
2003 TERATOLOGY SOCIETY MEETINGS: TRAVEL FOR STUDENTS
2003 年畸形学学会会议:学生旅行
- 批准号:
6669040 - 财政年份:2003
- 资助金额:
$ 5.15万 - 项目类别:
Response Signatures of Alcohol-Related Birth Defects
酒精相关出生缺陷的反应特征
- 批准号:
6533662 - 财政年份:2001
- 资助金额:
$ 5.15万 - 项目类别:
Response Signatures of Alcohol Related Birth Defects
酒精相关出生缺陷的反应特征
- 批准号:
6337388 - 财政年份:2001
- 资助金额:
$ 5.15万 - 项目类别:
Response Signatures of Alcohol-Related Birth Defects
酒精相关出生缺陷的反应特征
- 批准号:
6895693 - 财政年份:2001
- 资助金额:
$ 5.15万 - 项目类别:
Environmental Impact on the Embryonic mtDNA Genome
环境对胚胎 mtDNA 基因组的影响
- 批准号:
6518123 - 财政年份:1998
- 资助金额:
$ 5.15万 - 项目类别:
Environmental Impact on the Embryonic mtDNA Genome
环境对胚胎 mtDNA 基因组的影响
- 批准号:
6751933 - 财政年份:1998
- 资助金额:
$ 5.15万 - 项目类别:
相似海外基金
The pathogenesis of ALG14-congenital disorders of glycosylation.
ALG14-先天性糖基化障碍的发病机制。
- 批准号:
23K14967 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying New Therapeutics and Molecular Mechanisms in Congenital Disorders of Glycosylation.
确定先天性糖基化疾病的新疗法和分子机制。
- 批准号:
10644811 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Investigating the Genotype-Phenotype Relationships that Underlie Congenital Disorders with Cardiovascular Symptoms through Population-scale Analyses
通过人群规模分析研究具有心血管症状的先天性疾病背后的基因型-表型关系
- 批准号:
10724185 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Identifying understudied protein-related glycoproteome disruption in Congenital Disorders of Glycosylation
识别先天性糖基化障碍中尚未研究的蛋白质相关糖蛋白组破坏
- 批准号:
10725869 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Pathogenic Mechanisms of Congenital Disorders of Glycosylation
先天性糖基化障碍的发病机制
- 批准号:
10633548 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10480649 - 财政年份:2022
- 资助金额:
$ 5.15万 - 项目类别:
Assessment of a potential application of endogenous stem cells to treat congenital disorders
评估内源干细胞治疗先天性疾病的潜在应用
- 批准号:
22K20740 - 财政年份:2022
- 资助金额:
$ 5.15万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10616658 - 财政年份:2022
- 资助金额:
$ 5.15万 - 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
- 批准号:
10040788 - 财政年份:2020
- 资助金额:
$ 5.15万 - 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
- 批准号:
10250486 - 财政年份:2020
- 资助金额:
$ 5.15万 - 项目类别: